Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

How useful are beta-blockers in cardiovascular disease?

Bangalore S, Parkar S, Messerli FH.

Anadolu Kardiyol Derg. 2006 Dec;6(4):358-63. Review.

2.

Cardiovascular protection using beta-blockers: a critical review of the evidence.

Bangalore S, Messerli FH, Kostis JB, Pepine CJ.

J Am Coll Cardiol. 2007 Aug 14;50(7):563-72. Review.

3.

Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension.

Bangalore S, Sawhney S, Messerli FH.

J Am Coll Cardiol. 2008 Oct 28;52(18):1482-9. doi: 10.1016/j.jacc.2008.06.048.

4.

Cardioprotection with beta-blockers: myths, facts and Pascal's wager.

Messerli FH, Bangalore S, Yao SS, Steinberg JS.

J Intern Med. 2009 Sep;266(3):232-41. doi: 10.1111/j.1365-2796.2009.02140.x. Review.

5.
6.

[Do beta-blockers prevent coronary events in hypertensive patients?].

Diévart F, Ragot S, Julien J, Herpin D.

Arch Mal Coeur Vaiss. 2005 Sep;98(9):881-8. Review. French.

PMID:
16231574
7.

Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?

Dahlöf B, Devereux RB, Kjeldsen SE, Lyle PA, Zhang Z, Edelman JM.

Blood Press. 2007;16(1):6-12.

PMID:
17453746
8.

Beta-blockers: no longer an option for uncomplicated hypertension.

Bangalore S, Kamalakkannan G, Messerli FH.

Curr Cardiol Rep. 2007 Nov;9(6):441-6. Review.

PMID:
17999868
9.

Are we misunderstanding beta-blockers.

Cruickshank JM.

Int J Cardiol. 2007 Aug 9;120(1):10-27. Review.

PMID:
17433471
10.

[Risk management of coronary artery disease--pharmacological therapy].

Hofmann T.

Wien Med Wochenschr. 2004 Jun;154(11-12):266-81. Review. German.

PMID:
15287703
11.

The role of β-blockers in the management of hypertension: an Asian perspective.

Tomlinson B, Dalal JJ, Huang J, Low LP, Park CG, Rahman AR, Reyes EB, Soenarta AA, Heagerty A, Follath F.

Curr Med Res Opin. 2011 May;27(5):1021-33. doi: 10.1185/03007995.2011.562884. Review.

PMID:
21410302
12.

Beta-blockers in hypertensive and coronary heart disease.

Goldstein S.

Arch Intern Med. 1996 Jun 24;156(12):1267-76. Review.

PMID:
8651834
13.

Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).

Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA.

Am J Cardiol. 2009 Jul 15;104(2):151-7. doi: 10.1016/j.amjcard.2009.03.020.

PMID:
19576338
14.

[Beta blockers--1997 update].

Stoschitzky K, Klein W.

Wien Klin Wochenschr. 1997 Apr 11;109(7):222-31. Review. German.

PMID:
9206901
15.

A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.

Bangalore S, Parkar S, Grossman E, Messerli FH.

Am J Cardiol. 2007 Oct 15;100(8):1254-62.

PMID:
17920367
16.

Nebivolol: a third-generation beta-blocker for hypertension.

Cheng JW.

Clin Ther. 2009 Mar;31(3):447-62. doi: 10.1016/j.clinthera.2009.03.007. Review.

PMID:
19393838
17.

Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockade.

Bell DS.

Curr Med Res Opin. 2005 Aug;21(8):1191-200. Review.

PMID:
16083528
18.

[Do beta-blockers have a role in the modern treatment of arterial hypertension?].

Horký K.

Vnitr Lek. 1996 Jun;42(6):420-5. Review. Czech.

PMID:
8928415
19.

Beta-blockers to prevent symptomatic heart failure in patients with stage A and B heart failure.

Wild DM, Kukin M.

Curr Heart Fail Rep. 2007 Jun;4(2):99-102. Review.

PMID:
17521502
20.
Items per page

Supplemental Content

Support Center